Allscripts Acquires Oasis Medical Solutions

AllscriptsAllscripts (NASDAQ: MDRX) announced the acquisition of privately-held Oasis Medical Solutions Limited, a London-based Patient Administration System (PAS) and health informatics solution provider. The OasisTM PAS system, developed over 18 years in partnership with numerous NHS trusts, provides flexible, efficient and scalable administrative workflow across all venues of care. By combining the Oasis PAS technology with the Allscripts Sunrise clinical platform, Allscripts will offer a highly competitive, single-source offering for an innovative and advanced electronic patient record solution throughout the United Kingdom.

The Oasis PAS is used extensively across the NHS in more than a dozen NHS trusts and hospitals. Clients include East Sussex Healthcare, Royal Surrey County Hospital Trust, Medway NHS Foundation Trust and Worcestershire Acute Hospitals NHS Trust, among others. Oasis hospital clients average over 500 beds per facility, and the company has distinguished itself for its exclusive focus on PAS solutions for the NHS trusts that are innovative, effective, affordable and flexible.

Allscripts has a proven track record of success for clinical solutions, specifically the Allscripts Sunrise clinical electronic health record for inpatient and outpatient care management. Today, Sunrise is live at Liverpool Heart and Chest Hospital NHS Foundation Trust as well as at Salford Royal NHS Foundation Trust. In addition, Allscripts recently announced the opening of its European headquarters in Manchester, UK, committing additional resources to this important healthcare market.

By combining a leading PAS offering with its advanced clinical solution, Allscripts will provide the UK NHS trusts with the clear long-term advantages of integrated workflow between PAS and clinical solutions and the benefit of one business partner that provides a single-source electronic patient record to improve the efficiency and quality of healthcare delivery.

"The United Kingdom is an important growth market for Allscripts core clinical and PAS solutions," said Richard Berner, President, Allscripts International. "A strong clinical offering combined with a highly regarded PAS provides a complete and proven solution to meet the critical long-term needs of the NHS Trusts. By acquiring Oasis, we believe we have optimised our position in the market and expect to drive significant value from this combination for our clients."

Terms of the acquisition were not disclosed.

About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of HealthTM. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...